Zuschüsse an die Impfstoffhersteller Biontech und Curevac zur Corona-Impfstoffentwicklung

This procedure is a written parliamentary question regarding the public grants provided to the vaccine manufacturers BioNTech and CureVac. It seeks to clarify the terms and amounts of funding allocated to these companies for the development of COVID-19 vaccines. This inquiry affects the transparency of public spending in the healthcare sector and the relationship between the German government and pharmaceutical companies during the pandemic.